GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » 3-Year EBITDA Growth Rate

THCT (THC Therapeutics) 3-Year EBITDA Growth Rate : 0.00% (As of Apr. 2024)


View and export this data going back to 2007. Start your Free Trial

What is THC Therapeutics 3-Year EBITDA Growth Rate?

THC Therapeutics's EBITDA per Share for the three months ended in Apr. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of THC Therapeutics's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


THC Therapeutics's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's 3-Year EBITDA Growth Rate falls into.


;
;

THC Therapeutics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


THC Therapeutics  (OTCPK:THCT) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


THC Therapeutics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


THC Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135
Website
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.
Executives
Hiro Tanaka director, officer: Vice President 3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R director, officer: Chair of the Board 119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann director, 10 percent owner, officer: CEO, CFO 3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho director, officer: CEO 701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX